Oscar A Aguilar

11PUBLICATIONS
58CO-AUTHORS
Micro- and nanosystemsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 24, 2025
Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function.

Vincent Allain, Allison G Rothrock, Pierre-Louis Bernard

|Apr 01, 2025
Tumor cell heterogeneity drives spatial organization of the intratumoral immune response.

Miho Tanaka, Lotus Lum, Kenneth H Hu

|Mar 12, 2025
SYK negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.

Alberto J Millan, Vincent Allain, Indrani Nayak

|Jul 19, 2024
Spleen Tyrosine Kinase (SYK) negatively regulates ITAM-mediated human NK cell signaling and CD19-CAR NK cell efficacy.

Alberto J Millan, Vincent Allain, Indrani Nayak

|Apr 08, 2024
PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways.

Jiuling Yang, Li Wang, James R Byrnes

|Feb 27, 2024
ITAM-based receptors in natural killer cells.

Oscar A Aguilar, Lam-Kiu Fong, Lewis L Lanier

Pageof 2

Frequent Collaborators

9 joint publications

Lewis L Lanier

3 joint publications

Justin Eyquem

3 joint publications

Avishai Shemesh

3 joint publications

Vincent Allain